Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) closed the day trading at $23.18 down -1.15% from the previous closing price of $23.45. In other words, the price has decreased by -$1.15 from its previous closing price. On the day, 0.52 million shares were traded. AMPH stock price reached its highest trading level at $23.765 during the session, while it also had its lowest trading level at $23.04.
Ratios:
For a better understanding of AMPH, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.57 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.27. For the most recent quarter (mrq), Quick Ratio is recorded 2.02 and its Current Ratio is at 2.95. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.86.
On February 04, 2025, Piper Sandler Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $66 to $36.
On November 22, 2024, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $55.Wells Fargo initiated its Equal Weight rating on November 22, 2024, with a $55 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when Petersen Floyd F. sold 500 shares for $25.67 per share. The transaction valued at 12,835 led to the insider holds 72,909 shares of the business.
Petersen Floyd F. bought 500 shares of AMPH for $12,805 on Jun 02 ’25. On May 01 ’25, another insider, Petersen Floyd F., who serves as the Director of the company, sold 500 shares for $24.08 each. As a result, the insider received 12,041 and left with 73,409 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMPH now has a Market Capitalization of 1092684416 and an Enterprise Value of 1508333952. As of this moment, Amphastar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 8.41, and their Forward P/E ratio for the next fiscal year is 6.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.50 while its Price-to-Book (P/B) ratio in mrq is 1.47. Its current Enterprise Value per Revenue stands at 2.064 whereas that against EBITDA is 6.075.
Stock Price History:
The Beta on a monthly basis for AMPH is 0.74, which has changed by -0.42049998 over the last 52 weeks, in comparison to a change of 0.12463009 over the same period for the S&P500. Over the past 52 weeks, AMPH has reached a high of $53.96, while it has fallen to a 52-week low of $22.64. The 50-Day Moving Average of the stock is -6.27%, while the 200-Day Moving Average is calculated to be -34.68%.
Shares Statistics:
Over the past 3-months, AMPH traded about 559.69K shares per day on average, while over the past 10 days, AMPH traded about 449090 shares per day. A total of 47.67M shares are outstanding, with a floating share count of 34.58M. Insiders hold about 26.64% of the company’s shares, while institutions hold 72.37% stake in the company. Shares short for AMPH as of 1749772800 were 4080346 with a Short Ratio of 7.29, compared to 1747267200 on 4005726. Therefore, it implies a Short% of Shares Outstanding of 4080346 and a Short% of Float of 17.150000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
